Engrailed-2 protein as a potential urinary prostate cancer biomarker: a comparison study before and after digital rectal examination

This study was designed to compare and evaluate the presence of engrailed-2 (EN2) protein in urine collected before and after prostate massage as a diagnostic marker for prostate cancer (PCa). We analysed and compared 76 urine samples (38 before and 38 after prostate massage) from the benign group (...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of cancer prevention 2015-01, Vol.24 (1), p.51-56
Hauptverfasser: Marszałł, Michal Piotr, Sroka, Wiktor, Adamowski, Marek, Słupski, Piotr, Jarzemski, Piotr, Siódmiak, Joanna, Odrowąż-Sypniewska, Grażyna
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 56
container_issue 1
container_start_page 51
container_title European journal of cancer prevention
container_volume 24
creator Marszałł, Michal Piotr
Sroka, Wiktor
Adamowski, Marek
Słupski, Piotr
Jarzemski, Piotr
Siódmiak, Joanna
Odrowąż-Sypniewska, Grażyna
description This study was designed to compare and evaluate the presence of engrailed-2 (EN2) protein in urine collected before and after prostate massage as a diagnostic marker for prostate cancer (PCa). We analysed and compared 76 urine samples (38 before and 38 after prostate massage) from the benign group (BPH) and 66 urine samples (33 before and 33 after prostate massage) from patients with PCa confirmed by prostate biopsy. EN2 levels from the PCa and men with BPH (age range 50–82) were related to the tumour stage, Gleason score and prostate-specific antigen. EN2 levels were determined by enzyme-linked immunosorbent assay in urine. The median EN2 levels in urine after prostate massage were significantly different from those determined in urine before prostate massage (1.25 ng/ml in the PCa group and 0.34 ng/ml in the BPH). The mean EN2 levels in PCa patients were 3.76-fold higher than those in non-PCa patients after prostate massage. The distinct influence of prostate massage on EN2 levels was found to be related to the Gleason score and tumour stage. EN2 may be considered a marker of PCa with certain limitations, such as those related to tumour staging. The specificity and sensitivity of the protocol are highly dependent on prostate massage.
doi_str_mv 10.1097/CEJ.0000000000000046
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1628878522</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>48504406</jstor_id><sourcerecordid>48504406</sourcerecordid><originalsourceid>FETCH-LOGICAL-c348t-7e3b78b1084553cb8f2842db051849af2ecd34431dcb70910fdfe80df7c081533</originalsourceid><addsrcrecordid>eNpdUMtOwzAQtBCIlsIfAMqRS8r6FTtH1JaXKnGBs2U7DkpJk2I7h_49rloqwV52pZnZnR2ErjFMMZTifrZ4ncKfYsUJGmMmaM4FlKdoDCUvc0mEHKGLEFYAWFBcnKMR4QC0ADFG80X36XXTuion2cb30TVdpkOms02au9joNht802m_3cEh6ugyqzvrfGaafq39l_OX6KzWbXBXhz5BH4-L99lzvnx7epk9LHNLmYy5cNQIaTBIxjm1RtZEMlIZ4FiyUtfE2YoyRnFlTXoAQ13VTkJVCwsSc0on6G6_Nzn5HlyIat0E69pWd64fgsIFkVJITkiisj3VJtPBu1ptfJPcbhUGtctPpfzU__yS7PZwYTBrVx1Fv4Elws2esAqx90ecSQ6MQUF_ANOnc7M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1628878522</pqid></control><display><type>article</type><title>Engrailed-2 protein as a potential urinary prostate cancer biomarker: a comparison study before and after digital rectal examination</title><source>MEDLINE</source><source>JSTOR Archive Collection A-Z Listing</source><creator>Marszałł, Michal Piotr ; Sroka, Wiktor ; Adamowski, Marek ; Słupski, Piotr ; Jarzemski, Piotr ; Siódmiak, Joanna ; Odrowąż-Sypniewska, Grażyna</creator><creatorcontrib>Marszałł, Michal Piotr ; Sroka, Wiktor ; Adamowski, Marek ; Słupski, Piotr ; Jarzemski, Piotr ; Siódmiak, Joanna ; Odrowąż-Sypniewska, Grażyna</creatorcontrib><description>This study was designed to compare and evaluate the presence of engrailed-2 (EN2) protein in urine collected before and after prostate massage as a diagnostic marker for prostate cancer (PCa). We analysed and compared 76 urine samples (38 before and 38 after prostate massage) from the benign group (BPH) and 66 urine samples (33 before and 33 after prostate massage) from patients with PCa confirmed by prostate biopsy. EN2 levels from the PCa and men with BPH (age range 50–82) were related to the tumour stage, Gleason score and prostate-specific antigen. EN2 levels were determined by enzyme-linked immunosorbent assay in urine. The median EN2 levels in urine after prostate massage were significantly different from those determined in urine before prostate massage (1.25 ng/ml in the PCa group and 0.34 ng/ml in the BPH). The mean EN2 levels in PCa patients were 3.76-fold higher than those in non-PCa patients after prostate massage. The distinct influence of prostate massage on EN2 levels was found to be related to the Gleason score and tumour stage. EN2 may be considered a marker of PCa with certain limitations, such as those related to tumour staging. The specificity and sensitivity of the protocol are highly dependent on prostate massage.</description><identifier>ISSN: 0959-8278</identifier><identifier>EISSN: 1473-5709</identifier><identifier>DOI: 10.1097/CEJ.0000000000000046</identifier><identifier>PMID: 25003607</identifier><language>eng</language><publisher>England: Lippincott Williams &amp; Wilkins, a business of Wolters Kluwer Health</publisher><subject>Aged ; Aged, 80 and over ; Biomarkers, Tumor - urine ; Digital Rectal Examination - methods ; Digital Rectal Examination - standards ; Homeodomain Proteins - urine ; Humans ; Male ; Middle Aged ; Nerve Tissue Proteins - urine ; Prostatic Neoplasms - diagnosis ; Prostatic Neoplasms - urine ; Research paper</subject><ispartof>European journal of cancer prevention, 2015-01, Vol.24 (1), p.51-56</ispartof><rights>2014 Wolters Kluwer Health | Lippincott Williams &amp; Wilkins</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/48504406$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/48504406$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,803,27924,27925,58017,58250</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25003607$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Marszałł, Michal Piotr</creatorcontrib><creatorcontrib>Sroka, Wiktor</creatorcontrib><creatorcontrib>Adamowski, Marek</creatorcontrib><creatorcontrib>Słupski, Piotr</creatorcontrib><creatorcontrib>Jarzemski, Piotr</creatorcontrib><creatorcontrib>Siódmiak, Joanna</creatorcontrib><creatorcontrib>Odrowąż-Sypniewska, Grażyna</creatorcontrib><title>Engrailed-2 protein as a potential urinary prostate cancer biomarker: a comparison study before and after digital rectal examination</title><title>European journal of cancer prevention</title><addtitle>Eur J Cancer Prev</addtitle><description>This study was designed to compare and evaluate the presence of engrailed-2 (EN2) protein in urine collected before and after prostate massage as a diagnostic marker for prostate cancer (PCa). We analysed and compared 76 urine samples (38 before and 38 after prostate massage) from the benign group (BPH) and 66 urine samples (33 before and 33 after prostate massage) from patients with PCa confirmed by prostate biopsy. EN2 levels from the PCa and men with BPH (age range 50–82) were related to the tumour stage, Gleason score and prostate-specific antigen. EN2 levels were determined by enzyme-linked immunosorbent assay in urine. The median EN2 levels in urine after prostate massage were significantly different from those determined in urine before prostate massage (1.25 ng/ml in the PCa group and 0.34 ng/ml in the BPH). The mean EN2 levels in PCa patients were 3.76-fold higher than those in non-PCa patients after prostate massage. The distinct influence of prostate massage on EN2 levels was found to be related to the Gleason score and tumour stage. EN2 may be considered a marker of PCa with certain limitations, such as those related to tumour staging. The specificity and sensitivity of the protocol are highly dependent on prostate massage.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biomarkers, Tumor - urine</subject><subject>Digital Rectal Examination - methods</subject><subject>Digital Rectal Examination - standards</subject><subject>Homeodomain Proteins - urine</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Nerve Tissue Proteins - urine</subject><subject>Prostatic Neoplasms - diagnosis</subject><subject>Prostatic Neoplasms - urine</subject><subject>Research paper</subject><issn>0959-8278</issn><issn>1473-5709</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdUMtOwzAQtBCIlsIfAMqRS8r6FTtH1JaXKnGBs2U7DkpJk2I7h_49rloqwV52pZnZnR2ErjFMMZTifrZ4ncKfYsUJGmMmaM4FlKdoDCUvc0mEHKGLEFYAWFBcnKMR4QC0ADFG80X36XXTuion2cb30TVdpkOms02au9joNht802m_3cEh6ugyqzvrfGaafq39l_OX6KzWbXBXhz5BH4-L99lzvnx7epk9LHNLmYy5cNQIaTBIxjm1RtZEMlIZ4FiyUtfE2YoyRnFlTXoAQ13VTkJVCwsSc0on6G6_Nzn5HlyIat0E69pWd64fgsIFkVJITkiisj3VJtPBu1ptfJPcbhUGtctPpfzU__yS7PZwYTBrVx1Fv4Elws2esAqx90ecSQ6MQUF_ANOnc7M</recordid><startdate>20150101</startdate><enddate>20150101</enddate><creator>Marszałł, Michal Piotr</creator><creator>Sroka, Wiktor</creator><creator>Adamowski, Marek</creator><creator>Słupski, Piotr</creator><creator>Jarzemski, Piotr</creator><creator>Siódmiak, Joanna</creator><creator>Odrowąż-Sypniewska, Grażyna</creator><general>Lippincott Williams &amp; Wilkins, a business of Wolters Kluwer Health</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150101</creationdate><title>Engrailed-2 protein as a potential urinary prostate cancer biomarker</title><author>Marszałł, Michal Piotr ; Sroka, Wiktor ; Adamowski, Marek ; Słupski, Piotr ; Jarzemski, Piotr ; Siódmiak, Joanna ; Odrowąż-Sypniewska, Grażyna</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c348t-7e3b78b1084553cb8f2842db051849af2ecd34431dcb70910fdfe80df7c081533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biomarkers, Tumor - urine</topic><topic>Digital Rectal Examination - methods</topic><topic>Digital Rectal Examination - standards</topic><topic>Homeodomain Proteins - urine</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Nerve Tissue Proteins - urine</topic><topic>Prostatic Neoplasms - diagnosis</topic><topic>Prostatic Neoplasms - urine</topic><topic>Research paper</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Marszałł, Michal Piotr</creatorcontrib><creatorcontrib>Sroka, Wiktor</creatorcontrib><creatorcontrib>Adamowski, Marek</creatorcontrib><creatorcontrib>Słupski, Piotr</creatorcontrib><creatorcontrib>Jarzemski, Piotr</creatorcontrib><creatorcontrib>Siódmiak, Joanna</creatorcontrib><creatorcontrib>Odrowąż-Sypniewska, Grażyna</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of cancer prevention</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Marszałł, Michal Piotr</au><au>Sroka, Wiktor</au><au>Adamowski, Marek</au><au>Słupski, Piotr</au><au>Jarzemski, Piotr</au><au>Siódmiak, Joanna</au><au>Odrowąż-Sypniewska, Grażyna</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Engrailed-2 protein as a potential urinary prostate cancer biomarker: a comparison study before and after digital rectal examination</atitle><jtitle>European journal of cancer prevention</jtitle><addtitle>Eur J Cancer Prev</addtitle><date>2015-01-01</date><risdate>2015</risdate><volume>24</volume><issue>1</issue><spage>51</spage><epage>56</epage><pages>51-56</pages><issn>0959-8278</issn><eissn>1473-5709</eissn><abstract>This study was designed to compare and evaluate the presence of engrailed-2 (EN2) protein in urine collected before and after prostate massage as a diagnostic marker for prostate cancer (PCa). We analysed and compared 76 urine samples (38 before and 38 after prostate massage) from the benign group (BPH) and 66 urine samples (33 before and 33 after prostate massage) from patients with PCa confirmed by prostate biopsy. EN2 levels from the PCa and men with BPH (age range 50–82) were related to the tumour stage, Gleason score and prostate-specific antigen. EN2 levels were determined by enzyme-linked immunosorbent assay in urine. The median EN2 levels in urine after prostate massage were significantly different from those determined in urine before prostate massage (1.25 ng/ml in the PCa group and 0.34 ng/ml in the BPH). The mean EN2 levels in PCa patients were 3.76-fold higher than those in non-PCa patients after prostate massage. The distinct influence of prostate massage on EN2 levels was found to be related to the Gleason score and tumour stage. EN2 may be considered a marker of PCa with certain limitations, such as those related to tumour staging. The specificity and sensitivity of the protocol are highly dependent on prostate massage.</abstract><cop>England</cop><pub>Lippincott Williams &amp; Wilkins, a business of Wolters Kluwer Health</pub><pmid>25003607</pmid><doi>10.1097/CEJ.0000000000000046</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0959-8278
ispartof European journal of cancer prevention, 2015-01, Vol.24 (1), p.51-56
issn 0959-8278
1473-5709
language eng
recordid cdi_proquest_miscellaneous_1628878522
source MEDLINE; JSTOR Archive Collection A-Z Listing
subjects Aged
Aged, 80 and over
Biomarkers, Tumor - urine
Digital Rectal Examination - methods
Digital Rectal Examination - standards
Homeodomain Proteins - urine
Humans
Male
Middle Aged
Nerve Tissue Proteins - urine
Prostatic Neoplasms - diagnosis
Prostatic Neoplasms - urine
Research paper
title Engrailed-2 protein as a potential urinary prostate cancer biomarker: a comparison study before and after digital rectal examination
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T01%3A11%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Engrailed-2%20protein%20as%20a%20potential%20urinary%20prostate%20cancer%20biomarker:%20a%20comparison%20study%20before%20and%20after%20digital%20rectal%20examination&rft.jtitle=European%20journal%20of%20cancer%20prevention&rft.au=Marsza%C5%82%C5%82,%20Michal%20Piotr&rft.date=2015-01-01&rft.volume=24&rft.issue=1&rft.spage=51&rft.epage=56&rft.pages=51-56&rft.issn=0959-8278&rft.eissn=1473-5709&rft_id=info:doi/10.1097/CEJ.0000000000000046&rft_dat=%3Cjstor_proqu%3E48504406%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1628878522&rft_id=info:pmid/25003607&rft_jstor_id=48504406&rfr_iscdi=true